KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to 0.1.

  • Aquestive Therapeutics' Asset Utilization Ratio fell 11975.8% to 0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1, marking a year-over-year decrease of 11975.8%. This contributed to the annual value of 0.01 for FY2024, which is 9856.37% down from last year.
  • According to the latest figures from Q3 2025, Aquestive Therapeutics' Asset Utilization Ratio is 0.1, which was down 11975.8% from 0.13 recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Asset Utilization Ratio peaked at 0.87 during Q4 2023, and registered a low of 0.13 during Q2 2025.
  • For the 5-year period, Aquestive Therapeutics' Asset Utilization Ratio averaged around 0.48, with its median value being 0.54 (2021).
  • As far as peak fluctuations go, Aquestive Therapeutics' Asset Utilization Ratio skyrocketed by 13158.09% in 2022, and later crashed by 12684.47% in 2025.
  • Quarter analysis of 5 years shows Aquestive Therapeutics' Asset Utilization Ratio stood at 0.54 in 2021, then skyrocketed by 44.24% to 0.78 in 2022, then grew by 11.14% to 0.87 in 2023, then crashed by 98.9% to 0.01 in 2024, then tumbled by 1172.42% to 0.1 in 2025.
  • Its last three reported values are 0.1 in Q3 2025, 0.13 for Q2 2025, and 0.02 during Q1 2025.